Abstract
HCV is a worldwide problem and the need to assess the degree of fibrosis is the corner stone in its treatment. Liver biopsy has been used for years to assess the degree of fibrosis and activity but recently many non-invasive methods have emerged to replace it as aspartate transaminase/platelet ratio [APRI), abdominal ultrasonography measuring caudate/right lobe ratio and hepatic stiffness [Fibroscan). PurposeCorrelate the accuracy of Transient Elastography [Fibroscan) in comparison to liver biopsy as a non-invasive method for fibrosis assessment in chronic hepatitis C patients. MethodsThe study was done on 50 patients with chronic HCV [32 males and 18 females) for which liver biopsy and fibroscan were performed. ResultsThere was positive correlation of liver biopsy with fibroscan score, there was moderate agreement [matching) between liver biopsy and fibroscan the lowest matching were in F0 and the highest were in F3. ConclusionFibroscan has a good matching with liver biopsy in the detection of hepatic fibrosis and follow up of its progression.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Egyptian Journal of Radiology and Nuclear Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
